Accelerating the precision medicine opportunity in Scotland

27/08/2019

Queen Elizabeth Teaching and Learning Centre

There are several market and technology drivers impacting on precision medicine including an ageing population, increasing healthcare costs and the emergence of new disruptive technologies. Advances in technology are accelerating a shift in healthcare from reaction to prevention and early stage treatments and the global precision medicine market was estimated at almost $43bn in 2016 and is projected to rise to around $134bn by 2025.

Scotland’s ecosystem for precision medicine includes a strong network of universities, research institutions, NHS facilities, enterprise and skills agencies and industry bodies all focussed on developing, commercialising and implementing our world-class research in precision medicine. Scotland has a growing number of businesses involved in precision medicine, including new start-ups and in-movers involved in developing digital platforms for health data, informatics, AI and machine learning.

How do we make Scotland a world leader in precision medicine?

Agenda:

08.45 – Registration with tea, coffee and networking

09.15 – Open from the chair
Sandy Kennedy, Entrepreneurial Scotland

09.20 – Professor Dame Anna Dominiczak, University of Glasgow

09.50 – Benefits of the Scottish Precision Medicine ecosystem – an industry perspective
Harper Van Steenhouse, Bioclavis

10.15 – Successful IP strategies in Precision Medicine
Magnus Johnston, Haseltine Lake Kempner

10.40 – Discussion in Panel and Q&A

11.05 – Coffee Break

11.30 – Identifying the skill sets required to develop the precision medicine cluster in Scotland
Speaker to be announced

11.55 – Enabling access to funding and investors
Scottish Enterprise 

12.20 – Dr Carol Clugston, University of Glasgow

12.50 – Discussion in Panel and Q&A

13.20 – Chair to close

13.30 – Networking lunch